Effectiveness of a Mobile Health Management Program for Colorectal Cancer Survivors with Chronic Conditions

Not Applicable

Active, not recruiting

• Conditions: Diabetes Mellitus; Colo-rectal Cancer; Hypertension; Dyslipidemia

• Registration Number: NCT06759844
• Lead Sponsor: Seoul National University Hospital

Brief Summary

The goal of this clinical trial is to evaluate if a mobile health management program can improve chronic disease management among colorectal cancer survivors with comorbid conditions such as hypertension, diabetes, and dyslipidemia. The main questions it aims to answer are:

Does the mobile health application improve clinical outcomes such as blood pressure, blood glucose levels, and lipid profiles? Does the application enhance participants' health behaviors and self-management capabilities? Researchers will compare the mobile health application group to the educational booklet group to see if the digital intervention leads to better health outcomes and adherence to lifestyle changes

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-09
• Study First Submitted: 2024-11-13
• Study First Submitted QC: 2024-12-29
• Study Start: 2025-01-01
• Study First Posted: 2025-01-06
• Last Update Submitted: 2025-02-11
• Last Update Posted: 2025-02-13
• Primary Completion: 2025-09-30
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Individuals aged 19 years or older Colorectal cancer survivors (patients within 5 years of completion of curative treatments such as surgery, radiation therapy, or chemotherapy) who also have chronic conditions (hypertension, dyslipidemia, or diabetes)

Specific registration criteria:

Diabetes: Fasting blood sugar (FBS) ≥ 126 mg/dL or HbA1c ≥ 6.5% Dyslipidemia: Low-density lipoprotein cholesterol (LDL) ≥ 130 mg/dL Hypertension: Systolic blood pressure (SBP) ≥ 140 mmHg or Diastolic blood pressure (DBP) ≥ 90 mmHg Individuals who understand the purpose of this study and provide informed consent to participate Individuals who own and use a smartphone (able to use an ICT-based health management program)

Exclusion Criteria

• Individuals who are unable to speak, listen, or read in Korean Individuals determined by a physician to be physically or mentally unfit (e.g., shortness of breath, severe depression) to participate in the study Individuals who are deemed unable to use the ICT-based program

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Body Mass Index	From enrollment to the end of treatment at 3months	Check if the level has decreased
Physical Activity Levels	From enrollment to the end of treatment at 3months	Check if the level has decreased
Fasting Blood Sugar	From enrollment to the end of treatment at 3months	Check for decreased blood sugar levels
Hemoglobin A1c	From enrollment to the end of treatment at 3months	check if the level has decreased
Total Cholesterol	From enrollment to the end of treatment at 3months	Check if the level has decreased
LDL Cholesterol	From enrollment to the end of treatment at 3months	Check if the level has decreased
Systolic and Diastolic Blood Pressure	From enrollment to the end of treatment at 3months	Check if the level has decreased
Body Weight	From enrollment to the end of treatment at 3months	Check if the level has decreased

Secondary Outcome Measures

Name	Time	Method
Improvement in Health Management Capability	From enrollment to the end of treatment at 3months	Differences in Questionnaire of Self-Assessment Tool
Increase in Health Behavior Patterns	From enrollment to the end of treatment at 3months	Differences in Questionnaire of Health Behavior and Practice Index
Emotional and Subjective Health Status	From enrollment to the end of treatment at 3months	Differences in Questionnaire of Patient Health Questionnaire-9

Trial Locations

Locations (1)

SNU-SMG Boramae Medical Center; 🇰🇷 Seoul, Korea, Republic of